These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16061279)

  • 1. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
    Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
    Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
    Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z
    Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas].
    Han LP; Liu JF; Liu XR; Dong ZM; Suo ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):179-84. PubMed ID: 21500549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA2 expression is associated with aggressive features in ovarian carcinoma.
    Thaker PH; Deavers M; Celestino J; Thornton A; Fletcher MS; Landen CN; Kinch MS; Kiener PA; Sood AK
    Clin Cancer Res; 2004 Aug; 10(15):5145-50. PubMed ID: 15297418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas].
    Han LP; Dong ZM; Qiao YH; Nesland JM; Suo ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):606-10. PubMed ID: 16909613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
    Wu Q; Suo Z; Kristensen GB; Baekelandt M; Nesland JM
    Gynecol Oncol; 2006 Jul; 102(1):15-21. PubMed ID: 16499955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPHA2/EFNA1 expression in human gastric cancer.
    Nakamura R; Kataoka H; Sato N; Kanamori M; Ihara M; Igarashi H; Ravshanov S; Wang YJ; Li ZY; Shimamura T; Kobayashi T; Konno H; Shinmura K; Tanaka M; Sugimura H
    Cancer Sci; 2005 Jan; 96(1):42-7. PubMed ID: 15649254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ; Qiao YH; Suo ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphA2 overexpression is associated with angiogenesis in ovarian cancer.
    Lin YG; Han LY; Kamat AA; Merritt WM; Landen CN; Deavers MT; Fletcher MS; Urbauer DL; Kinch MS; Sood AK
    Cancer; 2007 Jan; 109(2):332-40. PubMed ID: 17154180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
    Holm R; Knopp S; Suo Z; Tropè C; Nesland JM
    J Clin Pathol; 2007 Oct; 60(10):1086-91. PubMed ID: 17158642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
    Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S
    Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
    Sharma S; Qian F; Keitz B; Driscoll D; Scanlan MJ; Skipper J; Rodabaugh K; Lele S; Old LJ; Odunsi K
    Gynecol Oncol; 2005 Oct; 99(1):183-8. PubMed ID: 16005946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.